Inventor · Berlin, DE

Stefan Prechtl

14Patents
2h-index
38Co-inventors
46Inventor score

Filing activity: Apr 24, 2010 → Mar 21, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9340528B2 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors Chemistry; Metallurgy 10 Active
US9643953B2 Substituted benzylpyrazoles Chemistry; Metallurgy 4 Active
US10266548B2 Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases Chemistry; Metallurgy 1 Active
US8551980B2 Substituted triazolopyridines Human Necessities 1 Active
US9555022B2 Substituted triazolopyridines Chemistry; Metallurgy 0 Active
US8729082B2 Substituted imidazoquinoxalines Human Necessities 0 Active
US9676766B2 Triazolopyridines Human Necessities 0 Active
US9468642B2 Imidazopyrazines Chemistry; Metallurgy 0 Active
US9265763B2 Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases General 0 Revoked
US10604532B2 Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Chemistry; Metallurgy 0 Active
US9422268B2 Substituted benzylpyrazoles General 0 Revoked
US9260412B2 Substituted benzylpyrazoles General 0 Revoked
US9416125B2 Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer General 0 Revoked
US9682995B2 Amino-substituted isothiazoles Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.